Try our corporate solution for free!
(212) 419-8286

Roche: top-selling drugs 2018-2019, by revenue

Roche is one of the top pharmaceutical companies globally. They have a variety of products and medications sold worldwide with oncology being a focus area of the company. As of 2019, Roche’s second top revenue generating drug was Herceptin (trastuzumab). Herceptin is a drug used in the treatment of some types of breast cancer. The drug generated about six billion Swiss francs in revenue during 2019.

Roche company overview

Roche is a multinational pharmaceutical company based in Basel, Switzerland. The company has two primary divisions: diagnostics and pharmaceuticals. Roche has experienced exceptional growth in recent years which can be seen in the increasing value of their sales globally. As well as sales, Roche has experienced significant growth in their research and development (R&D) expenditures. Roche has been named a leader in global pharma in several ways but has excelled in producing and selling oncologic pharmaceuticals specifically.


Oncology is a branch of medicine that focuses on the diagnosis and treatment of cancer. The number of new cancer drugs under development in the United States is also increasing every year with significant growth recently. Oncologics and antidiabetics are the top two drug therapy areas in the United States based on drug spending.

Selected leading drugs of pharmaceutical company Roche in 2018 and 2019, based on revenue

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until November 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

January 2020



Survey time period

2018 and 2019

Supplementary notes

This statistic was assembled from the Roche's annual report and the company's separated financial report. No value means no data was given.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.